Search Results 81-90 of 16612 for immunothérapie Bylaska

  1. Cutaneous B-cell lymphoma - Diagnosis and treatment - Mayo Clinic

    Other treatment options may include skin-directed medicines, chemotherapy and immunotherapy. Which treatment is right for you depends on the type of cutaneous B ...

  2. A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma - the ImmuneSense Study - Mayo Clinic

    The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma multiforme (GBM) participants ...

  3. Clinical trials - Oncology (Medical)

    Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas. Rochester, Minn. To investigate the efficacy of autologous Epstein-barr virus (EBV)- ...

  4. A Study to Assess Dendritic Cell Immunotherapy Plus Standard-of-Care to Treat Advanced Renal Cell Carcinoma - Mayo Clinic

    The purpose of this study is to evaluate CMN-001 in a randomized trial between standard-of-care (SOC) (first line ipilimumab+nivolumab followed by second line ...

  5. Mayo Clinic Radio: Immunotherapy / Melanoma / Birth Control

    But, there is fast becoming a fourth option for some types of cancer: immunotherapy, which is a biological therapy where the patient's own immune system is ...

  6. Mayo Clinic Radio: Immunotherapy / Melanoma / Birth Control

    But, there is fast becoming a fourth option for some types of cancer: immunotherapy, which is a biological therapy where the patient's own immune system is ...

  7. Targeted treatment for breast cancer - Mayo Clinic

    ... immunotherapy. The data and the science is so robust, it's so dynamic, it's changing all the time. And I would say really where we've gone was from this ...

  8. A Study to Evaluate Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC) - Mayo Clinic

    A Study to Evaluate Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-immunotherapy Setting for Metastatic or ...

  9. Cancer Clinical Trials - Medical Professionals

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  10. Cancer Treatment! Clinical Trials

    ... immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC) Rochester, MN. This randomized phase II trial studies how well ...